Supernus Pharmaceuticals Inc (SUPN) financials · rev $719.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Supernus Pharmaceuticals Inc (SUPN) rev $719.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $719.0M | $661.8M |
| Cost of Revenue | $74.6M | $77.9M |
| Gross Profit | $644.4M | $583.9M |
| Operating Income | -$62.3M | $81.7M |
| Net Income | -$38.5M | $73.9M |
| EPS (Diluted) | -$0.68 | $1.32 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.45B | $1.37B |
| Current Assets | $644.2M | $686.1M |
| Cash & Equivalents | $128.4M | $69.3M |
| Inventory | $112.5M | $54.3M |
| PP&E | $10.5M | $11.5M |
| Total Liabilities | $390.9M | $332.3M |
| Current Liabilities | $338.2M | $292.4M |
| Shareholders' Equity | $1.06B | $1.04B |
| Retained Earnings | $517.9M | $556.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $47.3M | $172.0M |
| CapEx | $1.34M | $725.0K |
| Investing Cash Flow | $4.11M | -$189.9M |
| Financing Cash Flow | $9.13M | $12.2M |
| Net Change in Cash | $60.6M | -$5.72M |
| Free Cash Flow | $46.0M | $171.2M |
FAQ
What is SUPN P/E and revenue?
Supernus Pharmaceuticals Inc (SUPN) rev $719.0M.
What is SUPN revenue?
Supernus Pharmaceuticals Inc last cached revenue is $719.0M (FY2025).
Is SUPN profitable?
Supernus Pharmaceuticals Inc last cached net income is -$38.5M (FY2025).
What are SUPN total assets?
Supernus Pharmaceuticals Inc last cached total assets are $1.45B (FY2025).
What is SUPN free cash flow?
Supernus Pharmaceuticals Inc last cached free cash flow is $46.0M (FY2025).
Not investment advice. Cached statements, not a live tape.